Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.verified

CHGCY

Price:

$23.78

Market Cap:

$11.93T

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2012-08-03

Stock Exchange

PNK

Ticker

CHGCY

The Enterprise Value as of November 2024 (TTM) for Chugai Pharmaceutical Co., Ltd. (CHGCY) is 11.54T

According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.54T. This represents a change of 192.09% compared to the average of 3.95T of the last 4 quarters.

Chugai Pharmaceutical Co., Ltd. (CHGCY) Historical Enterprise Value (quarterly & annually)

How has CHGCY Enterprise Value performed in the past?

The mean historical Enterprise Value of Chugai Pharmaceutical Co., Ltd. over the last ten years is 2.80T. The current 11.54T Enterprise Value has changed 41.10% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's Enterprise Value was at its highest in in the June 2020 quarter at 9.47T. The Enterprise Value was at its lowest in in the December 2014 quarter at 1.50T.

Quarterly (TTM)
Annual

Average

2.80T

Median

2.71T

Minimum

1.50T

Maximum

4.31T

Chugai Pharmaceutical Co., Ltd. (CHGCY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 68.04%

Maximum Annual Enterprise Value = 4.31T

Minimum Annual Increase = -34.05%

Minimum Annual Enterprise Value = 1.50T

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20233.89T54.17%
20222.52T-11.25%
20212.84T-34.05%
20204.31T68.04%
20192.57T-23.20%
20183.34T11.13%
20173.01T67.15%
20161.80T-19.15%
20152.23T48.57%
20141.50T21.12%

Chugai Pharmaceutical Co., Ltd. (CHGCY) Average Enterprise Value

How has CHGCY Enterprise Value performed in the past?

The current Enterprise Value of Chugai Pharmaceutical Co., Ltd. (CHGCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.09T

5-year avg

3.23T

10-year avg

2.80T

Chugai Pharmaceutical Co., Ltd. (CHGCY) Enterprise Value vs. Peers

How is CHGCY’s Enterprise Value compared to its peers?

Chugai Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Scilex Holding Company (285.15M), greater than Merck & Co., Inc. (284.66B), greater than Johnson & Johnson (396.75B), greater than Pfizer Inc. (225.71B), greater than Astellas Pharma Inc. (3.73T), greater than Bristol-Myers Squibb Company PFD CONV 2 (154.95B), greater than Otsuka Holdings Co., Ltd. (4.87T), less than Novartis AG (0), greater than AstraZeneca PLC (232.94B), greater than GSK plc (248.09B), greater than Roche Holding AG (54.96B), greater than Bristol-Myers Squibb Company (251.88B), greater than Horizon Therapeutics Public Limited Company (154.32B), greater than Gilead Sciences, Inc. (92.83M), greater than Sanofi (132.43B), greater than null (138.98B),

Build a custom stock screener for Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Chugai Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?

What is the 3-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?

What is the 5-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?

How does the current Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY) compare to its historical average?